154 related articles for article (PubMed ID: 22946339)
1. Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
Liu Y; Gao X; Deeb D; Arbab AS; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2012; 10(1):1-8. PubMed ID: 22946339
[TBL] [Abstract][Full Text] [Related]
2. Anticancer agent pristimerin inhibits IL-2 induced activation of T lymphocytes.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Gautam SC
J Exp Ther Oncol; 2016 Jul; 11(3):181-188. PubMed ID: 28471123
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production.
Sławińska-Brych A; Zdzisińska B; Czerwonka A; Mizerska-Kowalska M; Dmoszyńska-Graniczka M; Stepulak A; Gagoś M
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129408. PubMed ID: 31386885
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
Wei S; Sun T; Du J; Zhang B; Xiang D; Li W
Oncol Rep; 2018 Dec; 40(6):3213-3222. PubMed ID: 30272303
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.
Gao X; Deeb D; Liu Y; Gautam S; Dulchavsky SA; Gautam SC
Immunopharmacol Immunotoxicol; 2009; 31(3):477-84. PubMed ID: 19555200
[TBL] [Abstract][Full Text] [Related]
7. Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.
Harikumar KB; Kunnumakkara AB; Ahn KS; Anand P; Krishnan S; Guha S; Aggarwal BB
Blood; 2009 Feb; 113(9):2003-13. PubMed ID: 18952893
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.
Kunnimalaiyaan S; Sokolowski KM; Balamurugan M; Gamblin TC; Kunnimalaiyaan M
PLoS One; 2015; 10(5):e0127464. PubMed ID: 26011160
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.
Shikata Y; Yoshimaru T; Komatsu M; Katoh H; Sato R; Kanagaki S; Okazaki Y; Toyokuni S; Tashiro E; Ishikawa S; Katagiri T; Imoto M
Cancer Sci; 2017 Apr; 108(4):785-794. PubMed ID: 28122154
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.
Sławińska-Brych A; Król SK; Dmoszyńska-Graniczka M; Zdzisińska B; Stepulak A; Gagoś M
Chem Biol Interact; 2015 Oct; 240():110-8. PubMed ID: 26297991
[TBL] [Abstract][Full Text] [Related]
11. Increased IL-2 production in T cells by xanthohumol through enhanced NF-AT and AP-1 activity.
Choi JM; Kim HJ; Lee KY; Choi HJ; Lee IS; Kang BY
Int Immunopharmacol; 2009 Jan; 9(1):103-7. PubMed ID: 19019318
[TBL] [Abstract][Full Text] [Related]
12. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer.
Saito K; Matsuo Y; Imafuji H; Okubo T; Maeda Y; Sato T; Shamoto T; Tsuboi K; Morimoto M; Takahashi H; Ishiguro H; Takiguchi S
Cancer Sci; 2018 Jan; 109(1):132-140. PubMed ID: 29121426
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol induces paraptosis of leukemia cells through p38 mitogen activated protein kinase signaling pathway.
Mi X; Wang C; Sun C; Chen X; Huo X; Zhang Y; Li G; Xu B; Zhang J; Xie J; Wang Z; Li J
Oncotarget; 2017 May; 8(19):31297-31304. PubMed ID: 28415750
[TBL] [Abstract][Full Text] [Related]
14. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.
Chen PH; Chang CK; Shih CM; Cheng CH; Lin CW; Lee CC; Liu AJ; Ho KH; Chen KC
Neuropharmacology; 2016 Nov; 110(Pt A):362-375. PubMed ID: 27487563
[TBL] [Abstract][Full Text] [Related]
15. Xanthohumol chalcone acts as a powerful inhibitor of carcinogenesis in drug-resistant human colon carcinoma and these effects are mediated via G2/M phase cell cycle arrest, activation of apoptotic pathways, caspase activation and targeting Ras /MEK/ERK pathway.
Liu X; An LJ; Li Y; Wang Y; Zhao L; Lv X; Guo J; Song AL
J BUON; 2019; 24(6):2442-2447. PubMed ID: 31983118
[TBL] [Abstract][Full Text] [Related]
16. Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.
Zhang W; Pan Y; Gou P; Zhou C; Ma L; Liu Q; Du Y; Yang J; Wang Q
Oncol Rep; 2018 Jan; 39(1):280-288. PubMed ID: 29138867
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer.
Gao F; Li M; Zhou L; Liu W; Zuo H; Li W
Oncol Rep; 2020 Oct; 44(4):1365-1374. PubMed ID: 32945473
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.
Dokduang H; Yongvanit P; Namwat N; Pairojkul C; Sangkhamanon S; Yageta MS; Murakami Y; Loilome W
Oncol Rep; 2016 Apr; 35(4):2065-72. PubMed ID: 26794001
[TBL] [Abstract][Full Text] [Related]
20. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
